Search

Search Constraints

You searched for: Author/Creator Maruff, Paul T.

Search Results

1. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease. Issue 1 (23rd February 2022)

2. Deferiprone to delay dementia (the 3D trial): Human/Human trials: Other. (7th December 2020)

3. Deficits in learning are greater than memory dysfunction in preclinical Alzheimer's disease: Neuropsychology: Neuropsychological correlates of pathology — Novel and standard cognitive markers of disease. (7th December 2020)

4. Empirically derived composite cognitive test scores to predict preclinical and clinical stages of Alzheimer's disease. (31st December 2021)

5. HOPE4MCI trial: First trial targeting reduction of hippocampal overactivity to treat mild cognitive impairment due to Alzheimer's disease with AGB101: Human/Human trials: Other. (7th December 2020)

6. Initial exploration of a brain age score based on validated computerized cognitive assessments in Japanese individuals: Neuropsychology/Multicultural issues in assessment of dementia. (7th December 2020)

7. Magnetic resonance imaging subtypes in subjective cognitive decline: Neuroimaging / Optimal neuroimaging measures for early detection. (7th December 2020)

10. P1‐211: HEALTHY ADULTS WITH AMYLOID‐RELATED MEMORY DECLINE REPORT NO CONCOMITANT DECLINE IN SUBJECTIVE REPORTS OF THEIR MEMORY IMPAIRMENT. (1st July 2014)